News Article
Candesic provided commercial due diligence to YFM Equity Partners
YFM Equity Partners announced in February a £12.35m investment in Audiological Science Ltd, a leading independent audiology provider which currently works with nine NHS BSW Integrated Care Board (ICBs), delivering high-quality hearing care in community settings across the UK.
Candesic is pleased to have provided commercial due diligence to YFM Equity Partners in support of their recent investment. The Candesic team, led by Senior Partner Dr Michelle Tempest and Engagement Manager Dr Nicolas Correa de Calixto.
YFM Equity Partners’ latest investment in Audiological Science Ltd reinforces their commitment to scaling innovative businesses. This investment will support Audiological Science in expanding its clinical footprint, enhancing its service offering, and further strengthening its position in the sector. We congratulate YFM and the Audiological Science management team on this milestone and look forward to seeing their continued success.
